Fibroblast growth factor receptor 4 (FGFR4): a targetable regulator of drug resistance in colorectal cancerRichard Turkington, Patrick G. Johnston|Cell Death and Disease|2014Cited by 96
Alcohol intake, tobacco smoking, and esophageal adenocarcinoma survival: a molecular pathology epidemiology cohort studyR Stephen McCain, Helen G. Coleman, Stephanie G. Craig et al.|Cancer Causes & Control|2019Cited by 29
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinomaRichard Turkington, Richard D. Kennedy, Laura A. Knight et al.|Gut|2019Cited by 27